Electroconvulsive therapy: An experience at Universitaria Teleton Clinic
##plugins.themes.bootstrap3.article.sidebar##
PDF (Español (España))
FLIP
HTML (Español (España))
##plugins.themes.bootstrap3.article.main##
Electroconvulsive Therapy (ECT), is a therapeutic option to treat difficult patients like those suffering from recurrent depressive disorders. Previous research has shown its effectiveness, and a low rate of adverse effects. This is a descriptive observational research using patients undergoing electroconvulsive therapy from Clínica Universitaria Teletón between 2007 and 2008. The treatment was given to 19 patients, two received 2 cycles. 134 sessions were carried out in total. 12 patients had major depressive disorder. The electrodes were put bilateral in all cases. Most treatments were administered with a frequency of three sessions per week. The average duration of the crisis was 45.39 seconds per EEG. Thiopental was used in 132 sessions (91.6%) and propofol in 7 (4,9%). Succinylcholine was used as muscle relaxant in all sessions. Adverse effects were present in 35 sessions; most of them by abundant secretions in 4 sessions and headache in 9 sessions. Standardization of procedure will allow an appropriate use of data bases in subsequent studies, making a comparison of its several forms with ECT. Using follow-up scales of clinical improvement will help to determine the effectiveness of the treatment in our population.
Downloads
##plugins.themes.bootstrap3.article.details##
Taylor S. 2007. Electroconvulsive Therapy: A Review of History, Patient Selection, Technique, and Medication Management. Southern Medical Journal 100(5):494-500.
Posada J, Aguilar S, Magaña C. 2004. Prevalencia de trastornos mentales y uso de servicios: informe preliminar estudio nacional de salud mental. Revista Colombiana de Psiquiatría 33(3):241-260.
Sociedad española de Psiquiatría. 1999. Consenso Español sobre la Terapia Electroconvulsiva. Disponible en http://www.sepsiq.org
Linington A, Harris B. 1988. Fifty years of electroconvulsive therapy. Value undoubted, mode of action unknown. British Medical Journal 297:26-27.
Shoor M. 1950. The intensive electric shock therapy of chronic disturbed psychotic patients. American Journal of Psychiatry 107:279-282.
Rothschild D. 1951. Regressive shock therapy in schizophrenia. Diseases of the Nervious System 12:147-150.
Gazdag G., Baran B., Bitter I. 2007. Regressive and Intensive Methods of Electroconvulsive Therapy: A Brief Historical Note. Journal of Electroconvulsive Therapy 23(4):229-223.
Sanacora G. 2003. Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT. American Journal of Psychiatry 160:577-579.
Fink M. 2002. Catatonia and ECT: Meduna’s Biological Antagonism Hypothesis Reconsidered. World Journal of Biological Psychiatry 3(2):105-108.
Benkelfat C. 1988. Biochemical effects of electroconvulsotherapy. Encephale 14:273-281.
Gur E, Dremencov E. 2002. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT1A and 5-HT1B receptor activity in rat hippocampus and hypothalamus. Brain Research 952:52-60.
Taylor S. 2007. Electroconvulsive Therapy: A Review of History, Patient Selection, Technique, and Medication Management. Southern Medical Journal 100(5):494-498.
Hayakawa H, Shimizu M, Nishida A, Motohashi N, Yamawaki S. 1994. Increase in serotonin 1A receptors in the dentate gyrus as revealed by autoradiographic analysis following repeated electroconvulsive shock but not imipramine treatment. Neuropsychobiology 30:53-56.
Nowak G, Dulinski J. 1991. Effect of repeated treatment with electroconvulsive shock (ECS) on serotonin receptor density and turnover in the rat cerebral cortex. Pharmacology Biochemistry and Behavior 38:691-694.
Devanand DP. 1994. Does ECT alter brain structure?. American Journal of Psychiatry 151:957-970.
Li B, Suemaru K, Cui R, Kitamura Y, Gomita Y, Araki H. 2006. Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats. European Journal of Pharmacology 529:114-121.
Hestad KA. 2003. Raised Plasma Levels of Tumor Necrosis Factor [alpha] in Patients With Depression: Normalization During Electroconvulsive Therapy. Journal of Electroconvulsive Therapy 19(4):183-188.
Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. 2006. Effects on right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. Journal of Psychiatric Research 40:322-327.
American Psychiatric Association (APA). 2001. Task Force on Electroconvulsive Therapy. Disponible en www.psych.org
Mc Donald A, Walter G. 2001. The portrayad in american movies. Journal of Electroconvulsive Therapy 17(4):264-274.
Walter G, Mc Donald A. 2002. Medical student kwoledge and attitudes regarding ECT prior to and after viewing ECT screen from movies. Journal of Electroconvulsive Therapy 18(1):43-46.
Khalid N, Atkins M, Tredget J, Giles M, Champney-Smith K, Kirov G. 2008. The Effectiveness of Electroconvulsive Therapy in Treatment-Resistant Depression: A Naturalistic Study. Journal of Electroconvulsive Therapy 24(2):141-145.
Rosa MO, Rosa MA, Belegarde L, Bueno C, Fregni F. 2008. Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasilera de Psiquiatría 30(2):149-151.
MacPherson R, Loo C. 2008. Cognitive Impairment Following Electroconvulsive Therapy V Does the Choice of Anesthetic Agent Make a Difference? Journal of Electroconvulsive Therapy 21(1):52-56.
